Recognizing filamentous basidiomycetes as agents of human disease: A review.
Identifieur interne : 000297 ( Main/Corpus ); précédent : 000296; suivant : 000298Recognizing filamentous basidiomycetes as agents of human disease: A review.
Auteurs : Anuradha Chowdhary ; Shallu Kathuria ; Kshitij Agarwal ; Jacques F. MeisSource :
- Medical mycology [ 1460-2709 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- chemical , pharmacology : Antifungal Agents.
- chemical , therapeutic use : Antifungal Agents.
- drug therapy : Mycoses.
- microbiology : Mycoses.
- Basidiomycota, Humans, Microbial Sensitivity Tests.
Abstract
Filamentous basidiomycetes (BM) are common environmental fungi that have recently emerged as important human pathogens, inciting a wide array of clinical manifestations that include allergic and invasive diseases. We reviewed 218 reported global cases of BM fungi. The most common etiologic agent was Schizophyllum commune in 52.3% (114/218) of the cases followed by Hormographiella aspergillata (n = 13; 5.9%), Ceriporia lacerata (n = 11; 5%), and, rarely, Volvariella volvacea, Inonotus tropicalis, Irpex lacteus, Phellinus undulates, Perenniporia species, Bjerkandera adusta, Sporotrichum pruinosum, Phanerochaete steroids, and Cyclomyces tabacinus. These fungi are present in the environment as gilled mushrooms, shelf fungi, and bracket fungi. However, in clinical settings, they usually present as nonsporulating white moulds that are difficult to identify. Moreover, the GenBank database of these fungi is limited. Regarding the country-wise distribution of cases, Japan topped the list with about 43% (n = 94) of globally reported cases, followed by India (57; 26%), the United States (4%), Austria (3.2%), Iran (3.2%), France (2.8%), and the remaining one-third from 16 other countries. The respiratory tract was the most commonly afflicted site (n = 71), with the majority of the cases (42; 59.1%) being allergic in etiology and comprising 34 cases of allergic bronchopulmonary mycosis. Also, B. adusta has been implicated in a recently described clinical entity, that is, fungus associated chronic cough, reported exclusively from Japan. BM fungi-incited diseases are currently underdiagnosed due to lack of awareness and expertise, warranting comprehensive epidemiological and susceptibility studies to determine their prevalence and to predict a more appropriate therapy.
DOI: 10.1093/mmy/myu047
PubMed: 25202126
Links to Exploration step
pubmed:25202126Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recognizing filamentous basidiomycetes as agents of human disease: A review.</title><author><name sortKey="Chowdhary, Anuradha" sort="Chowdhary, Anuradha" uniqKey="Chowdhary A" first="Anuradha" last="Chowdhary">Anuradha Chowdhary</name><affiliation><nlm:affiliation>Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India dranuradha@hotmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Kathuria, Shallu" sort="Kathuria, Shallu" uniqKey="Kathuria S" first="Shallu" last="Kathuria">Shallu Kathuria</name><affiliation><nlm:affiliation>Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.</nlm:affiliation></affiliation></author><author><name sortKey="Agarwal, Kshitij" sort="Agarwal, Kshitij" uniqKey="Agarwal K" first="Kshitij" last="Agarwal">Kshitij Agarwal</name><affiliation><nlm:affiliation>Rajan Babu Institute of Pulmonary Medicine and Tuberculosis, Delhi, India.</nlm:affiliation></affiliation></author><author><name sortKey="Meis, Jacques F" sort="Meis, Jacques F" uniqKey="Meis J" first="Jacques F" last="Meis">Jacques F. Meis</name><affiliation><nlm:affiliation>Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25202126</idno><idno type="pmid">25202126</idno><idno type="doi">10.1093/mmy/myu047</idno><idno type="wicri:Area/Main/Corpus">000297</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000297</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Recognizing filamentous basidiomycetes as agents of human disease: A review.</title><author><name sortKey="Chowdhary, Anuradha" sort="Chowdhary, Anuradha" uniqKey="Chowdhary A" first="Anuradha" last="Chowdhary">Anuradha Chowdhary</name><affiliation><nlm:affiliation>Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India dranuradha@hotmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Kathuria, Shallu" sort="Kathuria, Shallu" uniqKey="Kathuria S" first="Shallu" last="Kathuria">Shallu Kathuria</name><affiliation><nlm:affiliation>Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.</nlm:affiliation></affiliation></author><author><name sortKey="Agarwal, Kshitij" sort="Agarwal, Kshitij" uniqKey="Agarwal K" first="Kshitij" last="Agarwal">Kshitij Agarwal</name><affiliation><nlm:affiliation>Rajan Babu Institute of Pulmonary Medicine and Tuberculosis, Delhi, India.</nlm:affiliation></affiliation></author><author><name sortKey="Meis, Jacques F" sort="Meis, Jacques F" uniqKey="Meis J" first="Jacques F" last="Meis">Jacques F. Meis</name><affiliation><nlm:affiliation>Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Medical mycology</title><idno type="eISSN">1460-2709</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antifungal Agents (pharmacology)</term><term>Antifungal Agents (therapeutic use)</term><term>Basidiomycota (MeSH)</term><term>Humans (MeSH)</term><term>Microbial Sensitivity Tests (MeSH)</term><term>Mycoses (drug therapy)</term><term>Mycoses (microbiology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antifungal Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antifungal Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Mycoses</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Mycoses</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Basidiomycota</term><term>Humans</term><term>Microbial Sensitivity Tests</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Filamentous basidiomycetes (BM) are common environmental fungi that have recently emerged as important human pathogens, inciting a wide array of clinical manifestations that include allergic and invasive diseases. We reviewed 218 reported global cases of BM fungi. The most common etiologic agent was Schizophyllum commune in 52.3% (114/218) of the cases followed by Hormographiella aspergillata (n = 13; 5.9%), Ceriporia lacerata (n = 11; 5%), and, rarely, Volvariella volvacea, Inonotus tropicalis, Irpex lacteus, Phellinus undulates, Perenniporia species, Bjerkandera adusta, Sporotrichum pruinosum, Phanerochaete steroids, and Cyclomyces tabacinus. These fungi are present in the environment as gilled mushrooms, shelf fungi, and bracket fungi. However, in clinical settings, they usually present as nonsporulating white moulds that are difficult to identify. Moreover, the GenBank database of these fungi is limited. Regarding the country-wise distribution of cases, Japan topped the list with about 43% (n = 94) of globally reported cases, followed by India (57; 26%), the United States (4%), Austria (3.2%), Iran (3.2%), France (2.8%), and the remaining one-third from 16 other countries. The respiratory tract was the most commonly afflicted site (n = 71), with the majority of the cases (42; 59.1%) being allergic in etiology and comprising 34 cases of allergic bronchopulmonary mycosis. Also, B. adusta has been implicated in a recently described clinical entity, that is, fungus associated chronic cough, reported exclusively from Japan. BM fungi-incited diseases are currently underdiagnosed due to lack of awareness and expertise, warranting comprehensive epidemiological and susceptibility studies to determine their prevalence and to predict a more appropriate therapy.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25202126</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2016</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2709</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>8</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Medical mycology</Title><ISOAbbreviation>Med Mycol</ISOAbbreviation></Journal><ArticleTitle>Recognizing filamentous basidiomycetes as agents of human disease: A review.</ArticleTitle><Pagination><MedlinePgn>782-97</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/mmy/myu047</ELocationID><Abstract><AbstractText>Filamentous basidiomycetes (BM) are common environmental fungi that have recently emerged as important human pathogens, inciting a wide array of clinical manifestations that include allergic and invasive diseases. We reviewed 218 reported global cases of BM fungi. The most common etiologic agent was Schizophyllum commune in 52.3% (114/218) of the cases followed by Hormographiella aspergillata (n = 13; 5.9%), Ceriporia lacerata (n = 11; 5%), and, rarely, Volvariella volvacea, Inonotus tropicalis, Irpex lacteus, Phellinus undulates, Perenniporia species, Bjerkandera adusta, Sporotrichum pruinosum, Phanerochaete steroids, and Cyclomyces tabacinus. These fungi are present in the environment as gilled mushrooms, shelf fungi, and bracket fungi. However, in clinical settings, they usually present as nonsporulating white moulds that are difficult to identify. Moreover, the GenBank database of these fungi is limited. Regarding the country-wise distribution of cases, Japan topped the list with about 43% (n = 94) of globally reported cases, followed by India (57; 26%), the United States (4%), Austria (3.2%), Iran (3.2%), France (2.8%), and the remaining one-third from 16 other countries. The respiratory tract was the most commonly afflicted site (n = 71), with the majority of the cases (42; 59.1%) being allergic in etiology and comprising 34 cases of allergic bronchopulmonary mycosis. Also, B. adusta has been implicated in a recently described clinical entity, that is, fungus associated chronic cough, reported exclusively from Japan. BM fungi-incited diseases are currently underdiagnosed due to lack of awareness and expertise, warranting comprehensive epidemiological and susceptibility studies to determine their prevalence and to predict a more appropriate therapy.</AbstractText><CopyrightInformation>© The Author 2014. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chowdhary</LastName><ForeName>Anuradha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India dranuradha@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kathuria</LastName><ForeName>Shallu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Kshitij</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Rajan Babu Institute of Pulmonary Medicine and Tuberculosis, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meis</LastName><ForeName>Jacques F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Med Mycol</MedlineTA><NlmUniqueID>9815835</NlmUniqueID><ISSNLinking>1369-3786</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Med Mycol. 2015 Nov;53(8):896-7</RefSource><PMID Version="1">26472778</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Med Mycol. 2015 Nov;53(8):898-9</RefSource><PMID Version="1">26472779</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000935" MajorTopicYN="N">Antifungal Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001487" MajorTopicYN="Y">Basidiomycota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009181" MajorTopicYN="Y">Mycoses</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antifungal susceptibility</Keyword><Keyword MajorTopicYN="N">filamentous basidiomycetes</Keyword><Keyword MajorTopicYN="N">nonsporulating moulds</Keyword><Keyword MajorTopicYN="N">sequencing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25202126</ArticleId><ArticleId IdType="pii">myu047</ArticleId><ArticleId IdType="doi">10.1093/mmy/myu047</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PhanerochaeteV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000297 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000297 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= PhanerochaeteV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:25202126
|texte= Recognizing filamentous basidiomycetes as agents of human disease: A review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:25202126" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a PhanerochaeteV1
| This area was generated with Dilib version V0.6.37. |  |